Insider NameBuy/SellCompany NameTickerAmountShares Change
Dec 28, 2023Dec 29, 2023McCamish Mark Anthony
Dir
SellAvadel Pharmaceuticals PlcAVDL$14.53$1M-52.81%
Aug 11, 2023Aug 15, 2023McCamish Mark Anthony
Dir
SellAvadel Pharmaceuticals PlcAVDL$14.93$432,614-16.94%
Sep 16, 2020Sep 18, 2020McCamish Mark Anthony
Dir
BuyAvadel Pharmaceuticals PlcAVDL$5.76$985,219+50.00%
Apr 01, 2020Apr 03, 2020McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$95.42$3M-87.64%
Jun 25, 2019Jun 27, 2019McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$11.02$90,391-11.90%
Jun 20, 2019Jun 24, 2019McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$11.04$91,626-12.03%
May 20, 2019May 23, 2019McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$12.1$199,726-21.37%
Apr 18, 2019Apr 23, 2019McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$18.12$299,054-21.37%
Mar 19, 2019Mar 22, 2019McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$18.15$299,401-21.37%
Feb 19, 2019Feb 22, 2019McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$14.99$247,343-21.37%
Jan 18, 2019Jan 24, 2019McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$14.59$291,892-68.89%
Dec 26, 2018Dec 28, 2018McCamish Mark Anthony
Pres
CEO
SellForty Seven, Inc.FTSV$15.9$190,806-57.06%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.